On the other hand, as TCP strongly inhibits IFITM3-mediated antiviral activity by targeting LSD1, it could be potentially applied as an adjuvant to increase RNA virus propagation in IFITM3-competent system so as to assist vaccine industry or infection models. The gene discussed is KDM1A; the disease is infection.